Home » TB-Drugome Provides New Targets for Anti-Tuberculosis Drug Discovery
TB-Drugome Provides New Targets for Anti-Tuberculosis Drug Discovery
Researchers at the University of California, San Diego School of Medicine and the University of Leeds have linked hundreds of federally approved drugs to more than 1,000 proteins in Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), opening new avenues to repurpose these drugs to treat TB.
ScienceDaily
ScienceDaily
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May